Corrigendum to “Herceptin-Mediated Cardiotoxicity: Assessment by Cardiovascular Magnetic Resonance”

Corrigendum to “Herceptin-Mediated Cardiotoxicity: Assessment by Cardiovascular Magnetic Resonance”

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	Cardiology Research and Practice
Online Access:	http://dx.doi.org/10.1155/crp/9818679
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Herceptin-Mediated Cardiotoxicity: Assessment by Cardiovascular Magnetic Resonance
by: Jin Jiang, et al.
Published: (2022-01-01)

Radiation Recall Reaction Induced by Adjuvant Trastuzumab (Herceptin)
by: Caroline Chung, et al.
Published: (2009-01-01)

Society for Cardiovascular Magnetic Resonance recommendations toward environmentally sustainable cardiovascular magnetic resonance
by: Kate Hanneman, et al.
Published: (2025-01-01)

Comparative Preclinical Evaluation of Tuznue Versus Referent Herceptin: A Registered Trastuzumab Biosimilar
by: Herve Bischoff, et al.
Published: (2025-04-01)

Validation of ELISA Test-system for Trastuzumab (Herceptin, Hertikad) quantitative determination in biological fluids
by: V. V. Pisarev, et al.
Published: (2023-05-01)

Pathophysiology of Doxorubicin-Mediated Cardiotoxicity
by: Roberto Arrigoni, et al.
Published: (2025-04-01)

Society for Cardiovascular Magnetic Resonance reference values (“normal values”) in cardiovascular magnetic resonance: 2025 update
by: Nadine Kawel-Boehm, et al.
Published: (2025-01-01)

Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations in patients with congenital heart disease
by: Lars Grosse-Wortmann, et al.
Published: (2024-01-01)

Corrigendum to “Acute myocardial calcification demonstrated on multimodal imaging” [Journal of Cardiovascular Magnetic Resonance 26S1 (2024) 100939]
by: Joni Tan, et al.
Published: (2024-01-01)

Hypofunction of macrophage chemotaxis contributes to defective efficacy of herceptin in HER2-positive breast cancer patients
by: Yu Song, et al.
Published: (2024-12-01)

Highlights of the Society for Cardiovascular Magnetic Resonance 2025 conference: Leading the way to accessible, efficient, and sustainable cardiovascular magnetic resonance
by: Claudia Prieto, et al.
Published: (2025-01-01)

Assessing Cardiomyocyte DNA Damage Using Cardiovascular Magnetic Resonance T1 Mapping
by: Mizuki Ichikawa, MD, et al.
Published: (2025-08-01)

Assessment of Cardiovascular Apoptosis in the Isolated Rat Heart by Magnetic Resonance Molecular Imaging
by: Karl-Heinz Hiller, et al.
Published: (2006-04-01)

Highlights of the Cardiovascular Magnetic Resonance 2024 Conference: the first joint European Association of Cardiovascular Imaging, European Society of Cardiovascular Radiology, and Society for Cardiovascular Magnetic Resonance conference
by: Jadranka Stojanovska, et al.
Published: (2025-01-01)

Diagnostic and Prognostic Value of Cardiac Magnetic Resonance for Cardiotoxicity Caused by Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
by: Jialian Li, et al.
Published: (2025-02-01)

Cardiovascular magnetic resonance worldwide: A global commitment to cardiovascular care
by: Carlos E. Rochitte
Published: (2025-01-01)

Synthesis and Biological Evaluation of Herceptin-Conjugated Liposomes Loaded with Lipocalin-2 siRNA for the Treatment of Inflammatory Breast Cancer
by: Marienid Flores-Colón, et al.
Published: (2025-07-01)

Cardiovascular magnetic resonance in patients with mitral valve prolapse
by: Stefano Figliozzi, et al.
Published: (2025-01-01)

Comprehensive prognosis assessment of cardiovascular magnetic resonance parametric mapping in light chain amyloidosis
by: Xiao Li, et al.
Published: (2025-01-01)

Cardiovascular complications in patients with cancer: focus on anthracycline-induced cardiotoxicity
by: I. T. Murkamilov, et al.
Published: (2021-03-01)

The Society for Cardiovascular Magnetic Resonance Registry at 150,000
by: Matthew S. Tong, et al.
Published: (2024-01-01)

Assessment of Left Ventricular Structural Remodelling in Patients with Diabetic Cardiomyopathy by Cardiovascular Magnetic Resonance
by: Yongning Shang, et al.
Published: (2016-01-01)

Prevalence of cardiovascular diseases and risk factor assessment in breast cancer survivors exposed to cardiotoxic therapy
by: Marina V. Vitsenya, et al.
Published: (2025-03-01)

Inequity of access to contrast-enhanced cardiovascular magnetic resonance in patients with chronic kidney disease: A survey from the British Society of Cardiovascular Magnetic Resonance
by: William E. Moody, et al.
Published: (2025-01-01)

Easing the strain of fetal cardiovascular magnetic resonance: Editorial for “Fetal cardiovascular magnetic resonance feature tracking myocardial strain analysis in congenital heart disease”
by: Alex J. Barker, et al.
Published: (2024-01-01)

Right-ventricular mechanics assessed by cardiovascular magnetic resonance feature tracking in children with hypertrophic cardiomyopathy.
by: Joanna Petryka-Mazurkiewicz, et al.
Published: (2021-01-01)

Reconstruction techniques for accelerating dynamic cardiovascular magnetic resonance imaging
by: Andrew Phair, et al.
Published: (2025-01-01)

Automatic flow planning for fetal cardiovascular magnetic resonance imaging
by: Sara Neves Silva, et al.
Published: (2025-01-01)

The Re-Diagnostic Value of Cardiac Magnetic Resonance for Cardiovascular Diseases
by: Xi Jia, et al.
Published: (2025-06-01)

Correction: HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast Cancer.
by: Merel Gijsen, et al.
Published: (2016-03-01)

Corrigendum to “An unusual case of varicella zoster encephalitis mimicking a glioblastoma on magnetic resonance imaging and magnetic resonance spectroscopy” [IDCases 39 (2025) e02124]
by: Brenden Nago, et al.
Published: (2025-01-01)

In-vivo assessment of myocardial calcium uptake using manganese-enhanced cardiovascular magnetic resonance in aortic stenosis
by: Abhishek Dattani, et al.
Published: (2024-01-01)

Pharmacogenetics in treatment of anthracycline-induced cardiotoxicity in women without prior cardiovascular diseases
by: E. V. Grakova, et al.
Published: (2023-01-01)

AI and Smart Devices in Cardio-Oncology: Advancements in Cardiotoxicity Prediction and Cardiovascular Monitoring
by: Luiza Camelia Nechita, et al.
Published: (2025-03-01)

Referenceless 4D flow cardiovascular magnetic resonance with deep learning
by: Chiara Trenti, et al.
Published: (2025-01-01)

Late gadolinium enhancement cardiovascular magnetic resonance with generative artificial intelligence
by: Omer Burak Demirel, et al.
Published: (2025-01-01)

A comprehensive evaluation of the left atrium using cardiovascular magnetic resonance
by: Maurice Pradella, et al.
Published: (2025-01-01)

Doppler ultrasound gating for adult cardiovascular magnetic resonance: Initial experience
by: Lucia D. Beissel, et al.
Published: (2025-01-01)

Cardiovascular Magnetic Resonance Imaging Evidence of Edema in Chronic Chagasic Cardiomyopathy
by: Andrés Diaz, et al.
Published: (2019-01-01)

Regional variability of cardiovascular magnetic resonance access and utilization in the United States
by: Jennifer M. Li, et al.
Published: (2024-01-01)